IRB Number
|
#2003-255
|
| Description |
This research study will evaluate
how well an experimental drug (a protein administered in the vein) is
tolerated and how effective it is in treating a Hereditary Angioedema (HAE)
attack. |
| What is expected of me? |
People having an attack will call
Dr. Craig within 4 hours of recognizing the symptoms of a moderately severe
hereditary angioedema attack. Blood tests, ECG and physical exam will be
done, a catheter will be inserted in the vein and the drug infused over 10
minutes. You will be monitored for 4-8 hours; contacted by phone for 5 days
after treatment; return to the clinic 7 and 28 days after treatment for
blood tests, ECG and physical exam. A daily diary will be done for the first
7 days after treatment. |
| Inclusion Criteria |
Age 10 or older. Diagnosed with hereditary angioedema. |
| Exclusion Criteria |
Pregnant, breastfeeding, abnormal liver or kidney function. |
| Length of Study |
28 days |
| Study Location |
Penn State Milton S. Hershey
Medical Center |
| Investigator Information |
Dr. Timothy Craig
Pulmonary/Allergy |
| To obtain more information about this study please contact: |
Cathy Mende
717-531-4513
cmende@psu.edu |
